Evaluating atypical dementia syndromes using positron emission tomography with carbon 11-labeled Pittsburgh compound B

Archives of Neurology

Volumn 64, Issue 8, 2007, Pages 1140-1144

  Ng, Steven Y ^a   Villemagne, Victor L ^a,b,c   Masters, Colin L ^b,c   Rowe, Christopher C ^a  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; TRACER; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; APHASIA; ARTICLE; BRAIN ATROPHY; CASE REPORT; DEPTH PERCEPTION; FEMALE; HEMISPHERE; HUMAN; LANGUAGE DISABILITY; MALE; MEMORY DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WORKING MEMORY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANILINE COMPOUNDS; APHASIA, PRIMARY PROGRESSIVE; ATROPHY; BRAIN; CARBON RADIOISOTOPES; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; SYNDROME; THIAZOLES; TISSUE DISTRIBUTION;

EID: 34547891450     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.8.1140     Document Type: Article

References (15)

1. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000;123(pt 3):484-498.
2. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging. 2000;21(6):845-861.
3. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
4. Mesulam MM, Weintraub S. Spectrum of primary progressive aphasia. Baillieres Clin Neurol. 1992;1(3):583-609.
5. Mesulam MM. Primary progressive aphasia: a language-based dementia. N Engl J Med. 2003;349(16):1535-1542.
6. Chawluk JB, Mesulam MM, Hurtig H, et al. Slowly progressive aphasia without generalized dementia: studies with positron emission tomography. Ann Neurol. 1986;19(1):68-74.
7. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45(7):789-793.
8. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy: neuropathologic correlations. Arch Neurol. 1994;51(3):269-274.
9. Freedman L, Selchen DH, Black SE, et al. Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings. J Neurol Neurosurg Psychiatry. 1991;54(5):443-448.
10. Aharon-Peretz J, Israel O, Goldsher D, Peretz A. Posterior cortical atrophy variants of Alzheimer's disease. Dement Geriatr Cogn Disord. 1999;10(6):483-487.
11. Nestor PJ, Caine D, Fryer TD, Clarke J, Hodges JR. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET. J Neurol Neurosurg Psychiatry. 2003;74(11):1521-1529.
12. Mathis CA, Bacskai BJ, Kajdasz ST, et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett. 2002;12(3):295-298.
13. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306-319.
14. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005;(11).
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82(4):239-259.